LivaNova closes $250M acquisition of TandemLife

LivaNova closed its $250 million acquisition of TandemLife, a developer of cardiopulmonary temporary support solutions. The deal included $200 million upfront and up to $50 million in milestone payments.

“The acquisition of TandemLife allows us to complement our portfolio with a complete set of solutions for extracorporeal life support and percutaneous mechanical circulatory support.”massdevice.com

• 1 source
• massdevice.comLivaNova closes $250m TandemLife buy - MassDeviceFink DensfordApr 6, 2018

Summarized from public sources; check the original articles before acting on it.